IRADIMED CORP — Director's Dealing 2022

Aug 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-08-04

Reporting Person: ALLEN MONTY K (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-04	Common Stock	S	3072	$37.7101	Disposed	16928	Direct

Footnotes

F1: This transaction was executed in one trade at $37.7101.